Yabing Nan
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 24, 2026
Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.Yabing Nan, Kunyu Wang, Menghan Hu
|Nov 24, 2025
IRG1/itaconate/NRF2/GSH axis in tumor-associated macrophages drives therapy resistance and immune evasion in BRCA1-deficient breast cancer.Yabing Nan, Sophie O'keefe, Xiadi He
|May 03, 2024
OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.Yabing Nan, Xiaowei Wu, Qingyu Luo
|Jun 22, 2022
DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma.Yabing Nan, Qingyu Luo, Xiaowei Wu
Pageof 1
